Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment (original) (raw)

Vascular endothelial growth factor biology for regenerative angiogenesis

Roberto Gianni-barrera

Swiss Medical Weekly

View PDFchevron_right

Therapeutic Angiogenesis in Ischemic Heart Disease: Gene or Recombinant Vascular Growth Factor Protein Therapy?

Jens Kastrup

Current Gene Therapy, 2003

View PDFchevron_right

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

Peter Vale

The Annals of Thoracic Surgery, 1999

View PDFchevron_right

Therapeutic Angiogenesis for Coronary Artery Disease

Eugene Sim

Annals of Internal Medicine, 2002

View PDFchevron_right

Gene therapy for angiogenesis, restenosis and related diseases

Mikko Turunen

Experimental Gerontology, 1999

View PDFchevron_right

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT)

Marja Hedman

Circulation, 2003

View PDFchevron_right

Angiogenesis by gene therapy: a new horizon for myocardial revascularization?

Basil S Lewis, Wolfgang Schaper

Cardiovascular Research, 1997

View PDFchevron_right

Gene therapy with a plasmid expressing the VEGF121 for the treatment of critical ischemic cardiopathy

Ariana Guillen

View PDFchevron_right

Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia

Tanveer Khan

Gene Therapy, 2003

View PDFchevron_right

Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer

Marja Hedman

Gene Therapy, 2009

View PDFchevron_right

VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial

Nancy Camack

Molecular Therapy, 2009

View PDFchevron_right

Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model

Luís Gowdak

Journal of Vascular Surgery, 2000

View PDFchevron_right

Therapeutic Angiogenesis: Protein and Gene Therapy Delivery Strategies

Shailen Patel

European Journal of Cardiovascular Risk, 1999

View PDFchevron_right

Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-B Combination Gene Therapy Prolongs Angiogenic Effects via Recruitment of Interstitial Mononuclear Cells and Paracrine Effects Rather Than Improved Pericyte Coverage of Angiogenic Vessels

Peter Baluk

Circulation Research, 2008

View PDFchevron_right

VEGF 165 Gene Therapy for Patients with Refractory Angina: Mobilization of Endothelial Progenitor Cells

Melissa Markoski, Thiago Dipp, Rodrigo Plentz

Arquivos Brasileiros de Cardiologia, 2013

View PDFchevron_right

Therapeutic myocardial angiogenesis with vascular endothelial growth factors

Larry Diaz

Molecular and Cellular Biochemistry, 2000

View PDFchevron_right

Increased Vascularity Detected by Digital Subtraction Angiography after VEGF Gene Transfer to Human Lower Limb Artery: A Randomized, Placebo-Controlled, Double-Blinded Phase II Study

Hanna Mussalo

Molecular Therapy, 2002

View PDFchevron_right

Adeno-Associated Virus-Mediated Transduction of VEGF165 Improves Cardiac Tissue Viability and Functional Recovery After Permanent Coronary Occlusion in Conscious Dogs

nikola arsic

2010

View PDFchevron_right

Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease

Thomas Henry

Gene Therapy, 2011

View PDFchevron_right

VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease

Bernd Laudenberg

The Annals of Thoracic Surgery, 2000

View PDFchevron_right

Angiogenic gene therapy: pre-clinical studies and phase I clinical data

Douglas Losordo, Peter Vale, Riyaz Bashir

Kidney International, 2002

View PDFchevron_right

Progress and prospects: hurdles to cardiovascular gene therapy clinical trials

Juha Hartikainen

Gene Therapy, 2011

View PDFchevron_right

Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease

Tanveer Khan

Gene Therapy, 2007

View PDFchevron_right

Angiogenesis: Bench to Bedside, Have We Learned Anything?

Joanna Wykrzykowska

Toxicologic Pathology, 2006

View PDFchevron_right

Therapeutic Angiogenesis and Vasculogenesis for Ischemic Disease

Asos Vales

View PDFchevron_right

Stabilized HIF‐1α is superior to VEGF for angiogenesis in skeletal muscle via adeno‐associated virus gene transfer

Teresa Pereira

The FASEB Journal, 2005

View PDFchevron_right

VEGF gene therapy cooperatively recruits molecules from the immune system and stimulates cell homing and angiogenesis in refractory angina

Renato Abdala Karam Kalil

Cytokine, 2017

View PDFchevron_right

Efficient Expression of the Vascular Endothelial Growth Factor Gene In Vitro and In Vivo, Using an Adeno-associated Virus Vector

Hyeon-cheol Gwon

Journal of Molecular and Cellular Cardiology, 2001

View PDFchevron_right

Stabilized HIF-1 is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer

Teresa Pereira

The FASEB Journal, 2005

View PDFchevron_right